Therapeutic Omegas for Triglyceride Suppression
TOTS
Pilot RCT Intervention Targeting Elevated Triglycerides With a Point-of-Care Meter and Omega-3 Fatty Acids to Normalize Triglycerides and Fetal Growth
1 other identifier
interventional
40
1 country
2
Brief Summary
This study plans to learn more about how an omega-3 fatty acid supplement effects triglyceride levels in pregnancy. Triglycerides are a type of fat found in your blood. Your body converts extra calories into triglycerides to be stored and used later for energy. It is normal for triglyceride levels to go up during pregnancy however some women have levels that are \~30-40% higher than normal when they reach their third trimester of pregnancy. Having high triglycerides in pregnancy may be related to an increased chance of having a baby that is large for their age. The goal of this study is to determine if taking an omega-3 fatty acid supplement can slow the rise in triglyceride levels later in pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable pregnancy
Started Nov 2021
Longer than P75 for not_applicable pregnancy
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 13, 2020
CompletedFirst Posted
Study publicly available on registry
April 16, 2020
CompletedStudy Start
First participant enrolled
November 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2026
ExpectedMay 11, 2026
May 1, 2026
4.4 years
April 13, 2020
May 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Maternal Fasting and Postprandial Triglycerides
Differences in maternal fasting and postprandial triglycerides between groups
34 weeks gestational age
Study Arms (2)
Omega 3 Supplementation
EXPERIMENTALSupplementation of 4g of DHA/EPA daily
Safflower Oil Supplement
PLACEBO COMPARATORSupplementation of Safflower Oil daily
Interventions
Participants will supplement 4g of Omega 3 fish oil daily (750DHA/250EPA)
Participants will consume 2.5g of a Safflower oil supplement daily
Eligibility Criteria
You may qualify if:
- Pregnant women between the ages of 21-39 yrs
- Pre-pregnancy BMI 28-39
- Fasting Triglyceride ≥120 mg/dL measured by 15 wks
You may not qualify if:
- Pre-gestational diabetes or prediabetes
- History of gestational diabetes,
- History of pre-eclampsia, spontaneous pre-term delivery, or gestational hypertension \<34wks
- Tobacco or illicit substance use
- Chronic steroid use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Colorado, Denverlead
- University of Oklahomacollaborator
Study Sites (2)
University of Colorado/Anschutz Medical Campus
Aurora, Colorado, 80045, United States
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104, United States
Related Publications (1)
Barbour LA, Farabi SS, Friedman JE, Hirsch NM, Reece MS, Van Pelt RE, Hernandez TL. Postprandial Triglycerides Predict Newborn Fat More Strongly than Glucose in Women with Obesity in Early Pregnancy. Obesity (Silver Spring). 2018 Aug;26(8):1347-1356. doi: 10.1002/oby.22246. Epub 2018 Jun 22.
PMID: 29931812BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Teri L Hernandez, PhD
University of Colorado, Denver
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 13, 2020
First Posted
April 16, 2020
Study Start
November 29, 2021
Primary Completion
April 30, 2026
Study Completion (Estimated)
May 31, 2026
Last Updated
May 11, 2026
Record last verified: 2026-05